Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hamamatsu Introduces New S12572 Series of MPPC Devices

Published: Tuesday, October 08, 2013
Last Updated: Monday, October 07, 2013
Bookmark and Share
New improved MPPC for general photon counting applications.

Hamamatsu Photonics have expanded and improved on their range of semi-conductor detectors, featuring photon counting capability, with the introduction of the brand new S12572 series of multi-pixel photon counter devices (MPPC).

This new series of general purpose MPPC offers drastically reduced afterpulsing compared to previous Hamamatsu MPPC detectors.

The S12572 series are 3x3mm devices supplied in compact surface mount plastic packages, or through-hole ceramic packages.

Various pixel configurations are available, with pitches of 25um, 50um and 100um and pixel numbers of 14,400, 3,600 and 900 respectively.

Each pixel contains a quenching resistor so that simultaneous photon events can be counted separately and with a high degree of accuracy.

The devices feature typical high gain values of 5.15E5 to 2.8E6, comparable to that achievable from a conventional photomultiplier tube.

Some other key areas of improvement to the MPPC include; greatly reduced dark count, reduced afterpulsing, increased photon detection efficiency, improvements in timing resolution and linearity as well as reduced crosstalk.

The result of these and other improvements means that the MPPC now has a much improved signal-to-noise ratio, wider operating voltage range, improved time resolution and a wider dynamic range.

With these improvements, the S12572 series are ideal for a variety of applications, including positron emission tomography, high-energy physics, DNA sequencing, fluorescence measurement, nuclear medicine, point of care systems, drug discovery, medical diagnostic equipment and environmental analysis.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Accessing Metabolic Information with Mass Spec
Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples.
Zika Epidemic Likely to End Within Three Years
A team of scientists has predicted that the current Zika epidemic is likely to end within three years because there will be too few people left to infect.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!